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Abstract
Background: The arachnoid granulations (AGs) are projections of the arachnoid membrane into the dural
venous sinuses. They function, along with the extracranial lymphatics, to circulate the cerebrospinal fluid (CSF)
to the systemic venous circulation. Disruption of normal CSF dynamics may result in increased intracranial
pressures causing many problems including headaches and visual loss, as in idiopathic intracranial hypertension
and hydrocephalus. To study the role of AGs in CSF egress, we have grown cells from human AG tissue in vitro
and have characterized their expression of those cytoskeletal and junctional proteins that may function in the
regulation of CSF outflow.
Methods:  Human AG tissue was obtained at autopsy, and explanted to cell culture dishes coated with
fibronectin. Typically, cells migrated from the explanted tissue after 7–10 days in vitro. Second or third passage
cells were seeded onto fibronectin-coated coverslips at confluent densities and grown to confluency for 7–10
days. Arachnoidal cells were tested using immunocytochemical methods for the expression of several common
cytoskeletal and junctional proteins. Second and third passage cultures were also labeled with the common
endothelial markers CD-31 or VE-cadherin (CD144) and their expression was quantified using flow cytometry
analysis.
Results:  Confluent cultures of arachnoidal cells expressed the intermediate filament protein vimentin.
Cytokeratin intermediate filaments were expressed variably in a subpopulation of cells. The cultures also
expressed the junctional proteins connexin43, desmoplakin 1 and 2, E-cadherin, and zonula occludens-1. Flow
cytometry analysis indicated that second and third passage cultures failed to express the endothelial cell markers
CD31 or VE-cadherin in significant quantities, thereby showing that these cultures did not consist of endothelial
cells from the venous sinus wall.
Conclusion: To our knowledge, this is the first report of the in vitro culture of arachnoidal cells grown from
human AG tissue. We demonstrated that these cells in vitro continue to express some of the cytoskeletal and
junctional proteins characterized previously in human AG tissue, such as proteins involved in the formation of gap
junctions, desmosomes, epithelial specific adherens junctions, as well as tight junctions. These junctional proteins
in particular may be important in allowing these arachnoidal cells to regulate CSF outflow.
Published: 13 October 2005
Cerebrospinal Fluid Research 2005, 2:9 doi:10.1186/1743-8454-2-9
Received: 10 June 2005
Accepted: 13 October 2005
This article is available from: http://www.cerebrospinalfluidresearch.com/content/2/1/9
© 2005 Holman et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Cerebrospinal Fluid Research 2005, 2:9 http://www.cerebrospinalfluidresearch.com/content/2/1/9
Page 2 of 12
(page number not for citation purposes)
Background
Our understanding of cerebrospinal fluid (CSF) egress
remains limited regarding fluid movement from the sub-
arachnoid space across the arachnoid granulations (AGs)
and into the venous sinuses. The classical view of CSF
egress is that arachnoid granulations are herniations of
the arachnoid membrane which project into the dural
venous sinuses and function to return CSF to the systemic
venous circulation [1,2]. In addition, it has long been rec-
ognized that there may be a lymphatic component to CSF
drainage, recent tracer studies in sheep have suggested
that extra-cranial lymphatics might account for as much as
40–48% of CSF outflow [3,4]. Similar results have not yet
been demonstrated conclusively in humans, and the rela-
tive importance of the two routes at physiologic and non-
physiologic intracranial pressures is uncertain. Hence, a
study of arachnoidal cell cultures and their proteins will
help in the understanding of CSF dynamics.
Impaired CSF circulation can result in increased intracra-
nial pressure, causing hydrocephalus, severe headaches,
tinnitus, diplopia, and transient visual obscurations. If left
untreated, chronic intracranial pressure can cause intracta-
ble headache and compressive optic nerve damage, caus-
ing irreversible blindness. To study the role of the
arachnoidal cells in CSF outflow and its pathologies, we
have developed an in vitro model of the CSF outflow path-
way across the arachnoid granulations. This model can be
applied to physiological as well as pathological condi-
tions of increased intracranial pressure, such as idiopathic
intracranial hypertension where it has been suggested that
CSF egress is impaired [5] by an increased resistance to
outflow at the AGs [6-8]. This in vitro model utilizes arach-
noidal cells cultured from human AG tissue seeded onto
filter membranes as a model for the CSF outflow pathway.
The first step in utilizing this model effectively is to con-
firm that human arachnoidal cells in vitro express some of
the cytoskeletal proteins [9,10] and junctional complexes
[11] that have been described previously in fixed AG tis-
sue using immunohistochemistry and electron micros-
copy. In particular, the junctional complexes including
gap junctions [11,12], desmosomes [10,11,13-18], epi-
thelial specific cell adhesion molecules (E-cadherin) [19-
21], and tight junctions [11,15-18] are important in medi-
ating cell-cell adhesion and communication. These pro-
teins allow the arachnoid cells to form a barrier to CSF
egress, regulating the return of CSF to the venous
circulation.
The mechanism by which the AG cells facilitate fluid
transport is still a topic of debate, though the similarity to
the drainage of aqueous humour across the endothelia of
Schlemm's canal has been noted by several authors
[22,23]. These studies have suggested that AG cells regu-
late fluid flow by a process of large transcellular vacuoles
that originate at the basal membrane of the cell and func-
tion as one-way valves [22,24,25]. Ultrastructural studies
of human AGs by Yamashima [16,17] have identified
large vacuoles and have also suggested that extracellular
cisterns between AG cells contribute to the passive trans-
port of CSF, presumably between transiently altered tight
junctions.
This paper describes the culture and characterization of
the cytoskeletal and junctional proteins expressed by
arachnoidal cells grown from human arachnoid granula-
tion explants. Using immunofluorescent microscopy and
flow cytometry, we have demonstrated the growth of
arachnoidal cells from human AG explants. We have
shown that these cells in culture express many of the same
cytoskeletal and junctional proteins that have previously
been identified in human AG tissue using immunohisto-
chemistry and electron microscopy.
Methods
Collection of brain tissue
Human brain tissue was obtained within 24 hours post-
mortem from the Ohio State University Regional Autopsy
Center. Tissue donors ranged in age from 22 to 88 years
old. Brain tissue was collected in accordance with the
guidelines and regulations set forth by the Office of
Responsible Research Practices Institutional Review Board
for human subjects at The Ohio State University
(IRB#2002H3018). At autopsy, AGs were collected by
resecting the superior sagittal sinus and lateral lacunae.
Prior to explantation the tissue was washed 3X in sterile
Dulbecco's phosphate buffered saline (D-PBS) (Cellgro
Mediatech, Herndon, VA), and then placed into a Petri
dish containing fresh culture media. Primary cell culture
medium was Dulbecco's Modified Eagle Medium/Ham's
F-12 Nutrient medium (50:50 v/v), with L-glutamine,
penicillin/streptomycin, amphotericin B (all Cellgro
Mediatech), and 10% newborn calf serum (Invitrogen
Gibco, Carlsbad, CA).
Explant procedure and cell culture
The explant procedure was performed under a dissecting
microscope. An individual granulation was secured with
micro-surgical forceps adjacent to the apical cap cell por-
tion of the granulation. Micro-surgical spring scissors were
used to cut just below the forceps as close as possible to
the cap of the granulation. Dissecting the apical portion of
the granulation ensured that the cap cell cluster was
explanted while minimizing the possibility that the
fibrous capsule, central core, or underlying arachnoid
membrane was explanted as well. The number of explants
from each tissue donor depended on the frequency of the
AGs on the surface of the brain and in the sinuses. Typical
tissue donors generated between 24–48 explants.Cerebrospinal Fluid Research 2005, 2:9 http://www.cerebrospinalfluidresearch.com/content/2/1/9
Page 3 of 12
(page number not for citation purposes)
The granulation was washed again in fresh culture
medium, and explanted into a 24-well culture plate
coated with a fibronectin solution of 30 µg human
fibronectin (Sigma, St. Louis, MO) per ml M199 culture
medium (Cellgro Mediatech). Culture medium was
added to each well, and the explants were allowed to
remain undisturbed in the incubator for a period of three
to four days. The medium was subsequently changed
every three to four days as needed. Upon confluency, the
cells were washed with D-PBS, and dissociated with
0.05% trypsin EDTA in Hanks buffered saline (Cellgro
Mediatech). Trypsinization would typically dissociate the
explanted AG tissue as well. At this point sterile forceps
were used to remove and discard the explanted tissue.
Culture media containing 10% serum was added to the
dissociated cells to inhibit the trypsin reaction and the
cells were spun down at 1300 RPM. The cell pellet was
resuspended and plated to a T-25 cm2 culture flask. In sub-
sequent passages, cells were grown in T-75 cm2 flasks.
Antibodies
The following monoclonal antibodies were used for
immunofluorescence microscopy at the dilutions indi-
cated: mouse anti-human cytokeratin antibody clones
AE1/AE3 (1:50, DakoCytomation, Carpinteria, CA),
mouse anti-connexin43 antibody (1:100, Zymed, San
Francisco, CA), Cy3 conjugated mouse anti-vimentin anti-
body (1:100, Sigma), mouse anti-human desmoplakin
1&2 antibody (1:40, Chemicon International, Temecula,
CA), FITC conjugated mouse anti E-cadherin antibody
(1:50, Becton Dickinson, Franklin Lakes, NJ), and FITC
conjugated mouse anti ZO-1 antibody (1:50, Zymed). The
secondary antibodies used were a fluorescein isothiocy-
anate (FITC)-conjugated goat anti-mouse IgG1 secondary
antibody (Sigma) or an Alexa Fluor 555 conjugated don-
key anti-mouse IgG1 antibody (Molecular Probes,
Eugene, OR) at a 1:50 dilution for 45 minutes at 37°C. All
primary and secondary antibodies were diluted in 10%
serum from the same species in which the secondary anti-
body was produced (i.e. goat or donkey serum).
Immunocytochemistry
Second or third passage cells were seeded onto fibronec-
tin-coated coverslips (Becton Dickinson) and grown to
confluency. Cell cultures were tested at 1–1.5 weeks post-
confluency for the presence of cytokeratins, vimentin,
connexin43, desmoplakins 1&2, E-cadherin, and ZO-1.
The cells were washed 3X with sterile D-PBS and fixed
with 3.7% paraformaldehyde for 10 minutes, then perme-
abilized with 0.2% Triton X-100 (Sigma) in PBS at 37°C
for 5 minutes. To block non-specific binding of the pri-
mary antibody, the cells were incubated for 30 minutes in
10% serum diluted in D-PBS from the same species in
which the secondary antibody was produced. Next, the
cells were incubated with the primary antibodies at the
dilutions indicated above for 60 minutes at 37°C. When
appropriate, the cells were washed in D-PBS and incu-
bated with the secondary antibody for 45 minutes. After
incubation with the secondary antibody, cells were
washed in D-PBS, counterstained with 4',6-diamidino-2-
phenylindole (DAPI), and mounted with an antifade rea-
gent (Prolong Gold with DAPI, Molecular Probes) onto
glass slides for visualization. The cell cultures were visual-
ized using a Zeiss Axiocam inverted microscope equipped
with DAPI, FITC, and Cy3 filter sets. As a negative control,
cells grown on a cover slip were stained following the
same procedure except the primary antibody was omitted.
A lack of staining was interpreted as a high specificity of
the primary antibody.
Labeling with endothelial markers for flow cytometry
Anti-VE-cadherin (CD144) purified IgG1 isotype with an
anti-IgG1 secondary antibody conjugated to phycoeryth-
rin (PE) (Becton Dickinson), and a FITC conjugated anti-
CD31 antibody (Becton Dickinson) were used for flow
cytometry analysis of approximately 3–5 × 106 cells. Cell
cultures at second or third passage were harvested and
spun down, in the same way as for passaging. The cells
were resuspended at a concentration of 106 cells/100 µL.
Unlabeled cells were used for control analysis and com-
pensation (106 cells). The remaining cells were labeled
with antibodies VE-cadherin (5 µL /106 cells) or CD31-
FITC (5 µL /106 cells). The cells were incubated with the
primary antibody at 4°C for 25–30 minutes, and then
washed with labeling buffer (PBS with 2 mM EDTA, 0.5%
bovine serum albumin). For the VE-cadherin experiments
cells were then incubated with an anti IgG1 PE secondary
antibody (10 µL/106 cells) for 25 minutes. The cells were
washed with labeling buffer and finally resuspended in
2% paraformaldehyde.
Flow cytometry analysis
Analysis was performed on a Becton-Dickinson FACS Cal-
ibur equipped with 4 photo multiplier tubes, allowing for
4-color analysis using a 488 nm air-cooled argon and a
633 nm helium-neon laser as excitation wavelengths. VE-
cadherin-PE or CD31-FITC expression was assessed
within labeled cell populations by comparing their fluo-
rescent expression to unstained control cells. Cells were
gated based on their forward and side scattered light (FSC
and SSC, respectively) to exclude cellular debris (low SSC
and FSC) as well as clumps of cells (large SSC and FSC)
that may give erroneous fluorescent readings. Only cells
that fell within the defined gate in the light scatter plot
were subsequently analyzed for fluorescent expression.
In the subsequent fluorescent analysis, unlabeled cells
were examined to determine their intrinsic PE or FITC flu-
orescence. To determine their intrinsic PE fluorescence,
unstained cells were excited with a 488 nm argon laserCerebrospinal Fluid Research 2005, 2:9 http://www.cerebrospinalfluidresearch.com/content/2/1/9
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and their fluorescent emission was detected in the FL2
channel which detects wavelengths from 564–604 nm.
Based on their fluorescent emission in the FL2 channel, a
gate was established in the PE fluorescence histogram that
was considered the intrinsic PE fluorescence by unlabeled
arachnoidal cells. In analyzing cells labeled with VE-cad-
herin-PE, cells were gated based on their light scatter (SSC
and FSC) using the same gate as for the unlabeled cells. In
the following fluorescent analysis, cells falling within the
predefined gate for intrinsic PE fluorescence were consid-
ered negative for VE-cadherin-PE expression.
A similar procedure was followed in analyzing cells for
CD31-FITC expression except that intrinsic FITC fluores-
cence was determined in unlabeled arachnoidal cells by
exciting cells with a 488 mn argon laser and detecting
their fluorescent emission in the FL1 channel which
detects fluorescent wavelengths from 515–545 nm.
Results
Arachnoidal cell culture
Cell migration from human AG explants was generally
seen within 7–10 days (Figure 1A). At confluency, arach-
noidal cells exhibited contact inhibition and grew in
monolayers with a densely packed polygonal morphology
and a cobblestone-like appearance characteristic of epi-
thelial cell types (Figure 1B). Cells could remain in conflu-
ent culture for as long as a month and passaged as many
as 5–6 times before exhibiting signs of senescence, mani-
fested by enlargement of the cells and the dramatic slow-
ing of cell growth rate.
In limited cases, some cultures became overgrown by
fibroblasts, identified as elongated spindle-shaped cells
with many processes. Their growth was marked by rapid
proliferation that could overgrow the arachnoidal cells in
cultures. In instances of fibroblast overgrowth, these cul-
tures were discarded and were not used for immunofluo-
rescent labeling or flow cytometry analysis.
Immunocytochemical labeling of cytoskeletal and junction 
proteins
Cells cultured from human AGs expressed the intermedi-
ate filament proteins vimentin and cytokeratin. Second
passage cell cultures were immunoreactive to the anti-
vimentin antibody (Figure 2A), and cells expressed this
protein uniformly throughout the cell cytoplasm. Addi-
tionally, a subpopulation of cells in second passage cul-
tures was immunoreactive to the anti-human cytokeratin
antibody (AE1/AE3), which recognizes a wide range of
human cytokeratins (Moll's designation 1–8, 10, 13–16,
19) [26]. The expression of cytokeratin in the arachnoidal
cell cultures varied between experiments. Often, only a
subset of stained cells expressed cytokeratins. Immunore-
active cells expressed cytokeratin intermediate filaments
in a perinuclear pattern, with long filaments surrounding
the nucleus in a basket-like structure (Figure 2B).
Cells cultured from AGs also stained positively for
connexin43, with immunofluorescent microscopy show-
ing punctate staining at cell-cell borders (Figure 2C, red
arrows). Expression of the ZO-1 protein at the cell mem-
brane between adjacent cells is seen in Figure 2D (white
arrows). The antibody deposition pattern can be seen at
cell-cell borders with overlapping cellular processes seen
as short linear structures in parallel. The expression of
desmoplakin 1&2 was similar to that of connexin43, with
punctate staining seen along the plasma membrane of
two adjoining cells (Figure 2E, white arrows). Finally, Fig-
ure 2F shows cells labeled with the FITC-conjugated E-
cadherin antibody. This antibody labeled cells at their
periphery, at cell-cell contacts (Figure 2D, white arrows),
in a pattern similar to the connexin43 or ZO-1 labeled
cells.
Cells were also incubated with a FITC conjugated goat
anti-mouse IgG1 secondary antibody only. The lack of
staining in the absence of the primary antibody indicates
a high specificity between the primary and secondary anti-
bodies (results not shown). Similar results were obtained
for cells incubated with only the Alexa Fluor 555 conju-
gated donkey anti-mouse IgG1 secondary antibody
(results not shown).
Immunocytochemical labeling experiments with antibod-
ies to cytoskeletal and junctional proteins were repeated at
least once for cultures grown from the same tissue donor.
Immunofluorescent labeling of cytoskeletal and junc-
tional proteins was repeated in at least three additional
tissue donors with positive staining seen in all cultures.
Images obtained from these experiments were similar to
those presented in Figure 2.
Flow cytometry analysis of endothelial markers
Cells cultured from human AGs at second and third pas-
sage were labeled with the antibodies to VE-cadherin-PE
or CD31-FITC and their expression of these endothelial
markers was quantified using flow cytometry. Figure 3A
shows the light scatter plot for the unlabeled control cells
in the VE-cadherin-PE experiments. The gate R1 (in red)
was selected to exclude any cellular debris (low SSC and
FSC) and clumps of cells (high SSC and FSC). Only events
(cells) falling within this gate were further analyzed for PE
fluorescence. Figure 3B shows PE fluorescence histogram
used to determine the intrinsic PE fluorescence in unla-
beled arachnoidal cell cultures. Gate M1 was created to
define the intrinsic PE fluorescence. Of the 4,497 events
that fell within R1 and were subsequently analyzed for flu-
orescence, 4,487 (99.8%) also fell within the gate M1. Fig-
ures 3C and 3D show the light scatter plot and PECerebrospinal Fluid Research 2005, 2:9 http://www.cerebrospinalfluidresearch.com/content/2/1/9
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Human AG explants and arachnoidal cells in culture Figure 1
Human AG explants and arachnoidal cells in culture. Human AG tissue was obtained at autopsy, usually within 24 
hours post-mortem and explanted into cell culture plates coated with fibronectin. A: Cells were seen migrating from the 
explant within 7–10 days. Bar = 200 µm. B: Arachnoidal cells grown from AG explants in confluent cultures exhibited polygonal 
cell morphology. Confluent cultures of arachnoidal cells packed in quite densely and displayed a cobblestone-like appearance 
common to epithelial cells in culture. Bar = 200 µm.Cerebrospinal Fluid Research 2005, 2:9 http://www.cerebrospinalfluidresearch.com/content/2/1/9
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Immunocytochemical staining of confluent cell cultures from human AG tissue on fibronectin coverslips Figure 2
Immunocytochemical staining of confluent cell cultures from human AG tissue on fibronectin coverslips. A: 
Arachnoidal cells in culture were incubated with a Cy3 conjugated anti-vimentin antibody. Cells expressed this intermediate fil-
ament protein uniformly throughout the cytoplasm. B: Arachnoidal cells were labeled with a broad spectrum anti-cytokeratin 
antibody and visualized with a FITC conjugated secondary antibody. Cells expressed the epithelial specific intermediate filament 
protein cytokeratin in a perinuclear pattern, though the expression of this protein was not uniform. C: Cells cultured from AG 
tissue were incubated with a connexin43 antibody and then visualized with a FITC conjugated secondary antibody. Immunolo-
calization of this protein in a punctuate pattern at cell-cell borders (red arrows) indicates that arachnoidal cells are able to 
form gap junctions in confluent culture. D: Tight junctions in confluent cultures were identified by immunoreactivity to a FITC 
conjugated ZO-1 antibody. The antibody deposition pattern can be seen at cell-cell borders (white arrow) with overlapping 
filapodia consisting of short linear structures in parallel. E: Arachnoidal cells in culture were labeled with an anti-desmoplakin 
antibody and revealed with an Alexa Fluor 555 conjugated secondary antibody. Confluent cultures were able to form desmo-
somes as evidenced by the punctuate staining along the membranes of adjacent cell borders (white arrows). F: E-cadherin 
immunoreactivity was demonstrated by incubating cells with a FITC conjugated antibody to E-cadherin. This epithelial specific 
cell adhesion molecule was expressed at the periphery of the cells, at cell-cell contacts (white arrows) in a pattern similar to 
that of connexin43 or ZO-1. All immunofluorescent images were taken at the same magnification. Bar= 50 µm.Cerebrospinal Fluid Research 2005, 2:9 http://www.cerebrospinalfluidresearch.com/content/2/1/9
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fluorescence histogram respectively for the cells labeled
with the VE-cadherin-PE antibody. The position of the
gates R1 and M1 remained unchanged from the control
analysis. Of the 2,601 events that fell within R1 and were
subsequently analyzed for VE-cadherin-PE expression,
2,308 (88.7%) also fell within gate M1 and were consid-
ered negative for VE-cadherin expression.
Similar results were obtained for the CD31-FITC labeled
cells (Figure 4). The analysis of the unstained control cells
is shown in figure 4A and 4B. The light scatter plot in fig-
ure 4A also shows the gate, R2 (in red), that was used for
subsequent FITC fluorescence analysis. Figure 4B displays
the fluorescence histogram that was used to determine the
intrinsic FITC fluorescence in unlabeled arachnoidal cell
Flow cytometry analysis of cells cultured from AG tissue for expression of the endothelial marker VE-cadherin-PE Figure 3
Flow cytometry analysis of cells cultured from AG tissue for expression of the endothelial marker VE-cad-
herin-PE. A: A scatter plot of unlabeled cells, showing a gate, R1, used to define the events subsequently analyzed for fluores-
cence. SSC and FSC are side scattered light and forward scattered light respectively. B: A histogram was created to determine 
the autofluorescence of unlabeled cells. The gate M1 is defined as the intrinsic PE fluorescence of unlabeled cells. C: A scatter 
plots of cells labeled with the endothelial marker VE-cadherin-PE. The position of the gate R1 was unchanged from the control 
analysis. D: A histogram of the cells labeled with VE-cadherin-PE that fell within the gate R1 and were analyzed for PE fluores-
cence. Of the 2,601 events that were analyzed, 2,308 (88.7%) fell within the gate, M1, and were considered negative for VE-
cadherin expression. The position of the gate, M1, remained unchanged from the control analysis.Cerebrospinal Fluid Research 2005, 2:9 http://www.cerebrospinalfluidresearch.com/content/2/1/9
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cultures. Of the 3,704 events that fell within the gate R2
and were subsequently analyzed for FITC fluorescence,
3,697 (99.8%) also fell within the gate M2 that was con-
sidered the intrinsic FITC fluorescence. Figures 4C and 4D
show the light scatter plot and FITC fluorescence
histogram respectively for the cells labeled with the
CD31-FITC antibody. The position of the gates R2 and M2
remained unchanged from the control analysis. Of the
3,767 events that fell within R2 and were subsequently
analyzed for CD31-FITC expression, 3,761 (99.8%) also
fell within the gate M2 and were considered negative for
CD31 expression. The failure of these cultures to express
the endothelial specific proteins CD31 and VE cadherin in
significant quantities indicated that cells cultured from
human AG explants were not significantly contaminated
by endothelia from the venous sinus lumen.
Flow cytometry analysis of cells cultured from AG tissue for expression of the endothelial marker CD31-FITC Figure 4
Flow cytometry analysis of cells cultured from AG tissue for expression of the endothelial marker CD31-FITC. 
A: A Scatter plot of unlabeled cells showing a gate, R2, which was created to define events that were subsequently analyzed for 
fluorescence. SSC and FSC are side scattered and forward scattered light respectively. B: Histogram used to determine the 
autofluorescence of unlabeled cells, with the gate M2 defined as the intrinsic FITC fluorescence. C: A scatter plot of cells 
labeled with the CD31-FITC antibody. The position of the gate R2 in the scatter plot was unchanged from the control analysis. 
D: Histogram of the 3,767 events that fell within R2 and were subsequently analyzed for CD31-FITC expression. Almost all 
events (99.8%) also fell within the gate M2, indicating that cells cultured from AG tissue did not express the endothelial marker 
CD31-FITC. The position of gate, M2, did not change from control analysis.Cerebrospinal Fluid Research 2005, 2:9 http://www.cerebrospinalfluidresearch.com/content/2/1/9
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Flow cytometry experiments quantifying the expression of
the endothelial markers were repeated with cells cultured
from two additional tissue donors. Similar results were
obtained to those presented in Figures 3 and 4. Thereafter,
it was concluded that endothelial cells were likely not a
contaminating cell type and further experiments were not
performed
Discussion
The role of the arachnoid granulations in CSF outflow has
been the focus of attention since the works of Weed nearly
90 years ago [1,2]. While the ultrastructure of the arach-
noid membrane and granulations has been studied exten-
sively with light and electron microscopy [11,15-
18,22,24,25,27-34], functional studies have been few.
Because they are located intracranially, it is difficult to
observe and measure flow across human AGs in vivo.
Hence functional studies have been restricted primarily to
animal models. Welch and Pollay have described in vitro
preparations in both monkey and canine [34,35], where
excised pieces of dura and arachnoid villi were perfused
with colloidal gold, yeast, erythrocytes, and polystyrene
microspheres. However, a significant proportion of the
preparations developed leaks (7 of 22 in monkeys). In
addition, the structure of the arachnoid villi and granula-
tions in primate and canines may not accurately represent
the structure of human arachnoid granulations [15,23].
To more closely study the role of arachnoid cells in CSF
outflow, we have undertaken efforts to isolate these cells
from human AG tissue.
To our best knowledge, this is the first demonstration of
primary arachnoidal cell cultures from human AG tissue.
Previously leptomeningeal cells have been cultured from
the human pia and arachnoid membranes [36-42], but
cultures from AG tissue have not been described. This
study showed that cells cultured from AG tissue have spe-
cific immunological characteristics and can be prepared
without contamination of adjacent endothelial cells.
In some limited cases, cultures of arachnoidal cells
became overgrown by fibroblasts. Fibroblast contamina-
tion was marked by a rapid growth rate that could over
grow the arachnoidal cells in culture. However, with the
current explant technique, it was possible to consistently
grow cultures that were predominantly free of fibroblasts
contamination. This was assessed by uniform cobblestone
morphology and a homogenous expression of junctional
proteins using immunofluorescence.
While care was taken when dissecting the AG tissue, it is
possible in some instances that portions of the underlying
arachnoid membrane were explanted as well. In such
cases, it would be difficult to distinguish cells of the arach-
noid membrane from arachnoidal cells from AGs. Differ-
ences in protein expression between cells lining the
arachnoid granulation and the arachnoid membrane have
not been reported and would not be expected, as the AGs
are continuous with the arachnoid membrane proper, and
are often described as projections of the arachnoid mem-
brane into the dural sinuses. There remain functional dif-
ferences inferred from differences in ultrastructure
between the cells of the arachnoid membrane and those
of the arachnoid granulation. The cells lining the arach-
noid granulations allow the passage of CSF to the venous
sinuses by forming transcellular vacuoles and extracellular
cisterns [16-18,22,24,25,43].
The possibility existed that several of the junctional pro-
teins could have been expressed by contaminating
endothelial cells from the venous sinus lumen. The flow
cytometry analysis, however, demonstrated that arachnoi-
dal cell cultures did not express endothelial markers in sig-
nificant quantities. Compared to unlabeled control cells,
approximately 10% of VE-cadherin-PE labeled cells
expressed this marker positively. It was possible that this
constituted a small endothelial population within these
cultures, though further inspection of this histogram (Fig-
ure 3D) did not reveal a second population of PE positive
cells. Taken together with the nearly complete lack of
CD31 expression (>99%), this strongly suggests that
endothelial cells were not present in significant quantities
in cultures from AG explants.
To characterize the profile of immunological markers
expressed by arachnoidal cells grown from human AG tis-
sue, cultures were labeled with fluorescently conjugated
antibodies to several cytoskeletal and junctional proteins.
Vimentin intermediate filament expression has been char-
acterized extensively using immunohistochemistry in the
cells of the arachnoid membrane, granulations, and men-
ingiomas [9,10,14,44,45], as well as in cultured human
leptomeningeal cells [37,39-41]. Cells cultured from AG
tissue uniformly expressed vimentin intermediate
filaments.
The connexins are found in cells containing gap junctions,
providing a pathway for direct intercellular
communication for ions, amino acids, and nucleotides.
Gap junctions have been identified in human arachnoid
membranes and AGs using electron microscopy, freeze
fracture, and immunohistochemistry [11,12]. Grafstein et
al. [39] demonstrated connexin43 expression in cultures
of human leptomeningeal cells and showed that these
cells could propagate calcium waves suggesting a pathway
for intercellular communication. The presence of gap
junctions in cell cultured from AGs may provide a path-
way for intercellular communication, allowing the regula-
tion of CSF passage.Cerebrospinal Fluid Research 2005, 2:9 http://www.cerebrospinalfluidresearch.com/content/2/1/9
Page 10 of 12
(page number not for citation purposes)
Desmosomal junctions are typically found in cells of epi-
thelial origin. They function to anchor bundles of inter-
mediate filaments at desmoplakin proteins [46]. While
most desmoplakins associate with cytokeratin filaments,
exceptions have been found, including the arachnoid cells
that anchor vimentin intermediate filaments at these
plaques. The presence of desmosomes has been identified
with electron microscopy, freeze fracture, and immuno-
histochemistry [10,11]. Desmosomal junctions are also
expressed by in vitro cultures of leptomeningeal cells and
have been used as a specific marker for these cells [40].
The presence of desmosomes in the in vitro cultures from
human AGs indicates that these cultures are of arachnoi-
dal origin.
Cadherins are cell adhesion molecules that are largely
responsible for calcium dependent cell-cell adhesion. Sev-
eral types have been described, including N-cadherin in
neural and muscle tissue, P-cadherin in placental tissue, E-
cadherin found in epithelial cells, and VE-cadherin
expressed exclusively in endothelial cells [47,48]. The
expression of E-cadherin has been demonstrated in the
flash frozen arachnoid membrane, granulations and men-
ingioma tissue using standard immunohistochemistry
[19-21]. E-cadherin functions in AG cells to bind the
arachnoid cells lining the arachnoid villi and granulations
together flexibly and may allow the formation of extracel-
lular cisterns during the bulk outflow of CSF [20]. The in
vitro expression of E-cadherin by cells cultured from AG
tissue demonstrated that these cells were epithelial and
could form cell-cell junctions that may be necessary to
regulate the passage of fluid.
The zonula occludens (ZO proteins) are peripheral mem-
brane proteins that associate with other proteins in tight
junctions where they serve to anchor the actin cytoskele-
ton. In epithelial cells, these junctions maintain polarity
and regulate the paracellular passage of ions, macromole-
cules, and water. While tight junctions have been recog-
nized in the arachnoid cells lining the AGs [15-17], these
junctions have not been described in cells cultured from
the leptomeninges. Demonstrating the presence of tight
junctions in cells cultured from AG tissue cultures, suggest
that these cells have the potential to form a barrier to fluid
flow.
The expression of cytokeratin filaments in the arachnoid
membrane and granulations has been the subject of
debate. The association of intermediate filaments with
desmosomal junctions in meningiomas, arachnoid mem-
brane, and arachnoid granulations was first reported by
Kartenbeck et al. and Schwecheimer et al. [10,14], who
demonstrated that desmosomal plaques anchored vimen-
tin filaments, while cytokeratin immunoreactivity within
these tissues was not found. Subsequent immunohisto-
chemical studies have also failed to find cytokeratin
expression in the meninges and AGs [44,45,49]. However,
cytokeratin positive cells within the arachnoid have been
recognized in limited cases [50,51]. Several published
reports of cultured leptomeningeal cells show that these
cells express cytokeratin uniformly [38,40,41]. Of note are
studies by Frank et al. [38] and Murphy et al. [40] focusing
on cultured leptomeningeal cells grown from human
arachnoid membranes.
The variability in cytokeratin expression may be related to
the embryological origin of the meninges. The develop-
ment of the meninges has been described in detail by
O'Rahilly and Müller [52], who suggest that there are sev-
eral possible sources for the human cranial meninges,
including the parachordal mesoderm, mesectoderm, and
other neuroectodermal elements. Embryological contri-
bution from mesodermal as well as neuroectodermal ele-
ments may explain the later mesenchymal and epithelial
properties of the adult meninges. Arachnoid cells appear
to express both epithelial and mesenchymal properties
[36,44,45,49]; mesenchymal by their ability to express
vimentin intermediate filaments and synthesize basement
membrane proteins (collagen type I and IV, fibronectin,
laminin) [37], and epithelial through the formation of
cell-cell junctions [11].
Since cytokeratin expression has not been found consist-
ently in human arachnoid membrane and granulation tis-
sue, it seems anomalous that cells cultured from these
tissues should express cytokeratins uniformly. In identify-
ing arachnoidal cells within these cultures, the formation
of cell-cell junctions may be more relevant to recapitulate
these cells' in vivo function, regulating the outflow of CSF.
Future studies will focus on characterizing these cells' abil-
ity to form an occluding barrier to fluid flow using a per-
fusion chamber and hydrostatic pressure control. Cells are
perfused and fixed under pressure, and the cellular
ultrastructure is examined using electron microscopy.
These studies will also try to determine whether arachnoi-
dal cells in vitro can mimic the one-directional flow of CSF
in vivo.
Conclusion
These results show what we believe to be the first demon-
stration and characterization of arachnoidal cells cultured
from human AG tissue. We have demonstrated the in vitro
expression of several important cytoskeletal and junc-
tional proteins previously identified in AG tissue by
immunohistochemistry and electron microscopy. The
expression of these junctional proteins is an important
first step in demonstrating that arachnoidal cells grown
from human AG tissue in vitro can exhibit some of theCerebrospinal Fluid Research 2005, 2:9 http://www.cerebrospinalfluidresearch.com/content/2/1/9
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barrier properties previously recognized in intact AG tis-
sue and may allow these cells to regulate CSF outflow.
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